The Nucleic Acid Methylation Market is gaining significant attention due to its crucial role in epigenetics, biomarker discovery, disease diagnostics, and therapeutic development. Nucleic acid methylation involves the addition of methyl groups (–CH₃) to DNA or RNA molecules, influencing gene expression, genomic stability, and cellular processes without altering the underlying nucleotide...

In 2024, the global nucleic acid methylation market was valued at USD 3.43 billion and is projected to reach USD 7.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.69% between 2025 and 2030. This robust expansion is largely attributed to the rising adoption of methylation markers for early disease detection and the creation of novel drugs targeting m⁶A...